American Century Companies Inc. Buys 63,146 Shares of Phreesia, Inc. $PHR

American Century Companies Inc. lifted its stake in Phreesia, Inc. (NYSE:PHR) by 6.4% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,046,586 shares of the company’s stock after acquiring an additional 63,146 shares during the period. American Century Companies Inc.’s holdings in Phreesia were worth $29,786,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Farther Finance Advisors LLC boosted its position in Phreesia by 9,375.0% during the second quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock worth $86,000 after purchasing an additional 3,000 shares during the period. Smartleaf Asset Management LLC lifted its stake in shares of Phreesia by 53.0% in the first quarter. Smartleaf Asset Management LLC now owns 5,267 shares of the company’s stock worth $137,000 after buying an additional 1,825 shares during the last quarter. Entropy Technologies LP acquired a new stake in shares of Phreesia in the first quarter worth $202,000. AlphaQuest LLC boosted its holdings in shares of Phreesia by 294.8% during the 1st quarter. AlphaQuest LLC now owns 8,216 shares of the company’s stock worth $210,000 after buying an additional 6,135 shares during the period. Finally, Virtus Advisers LLC acquired a new position in Phreesia in the 1st quarter valued at $235,000. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Phreesia Stock Down 0.2%

NYSE PHR opened at $20.50 on Monday. Phreesia, Inc. has a twelve month low of $18.55 and a twelve month high of $32.76. The stock has a market cap of $1.23 billion, a PE ratio of -48.80 and a beta of 0.74. The firm has a 50-day simple moving average of $22.45 and a 200 day simple moving average of $25.45. The company has a debt-to-equity ratio of 0.02, a quick ratio of 2.12 and a current ratio of 2.12.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Thursday, September 4th. The company reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.07) by $0.08. Phreesia had a negative return on equity of 8.75% and a negative net margin of 5.35%.The firm had revenue of $117.26 million during the quarter, compared to analysts’ expectations of $116.39 million. During the same quarter in the prior year, the firm posted ($0.03) EPS. The company’s revenue for the quarter was up 14.9% on a year-over-year basis. Phreesia has set its FY 2026 guidance at EPS. On average, research analysts forecast that Phreesia, Inc. will post -1.1 EPS for the current year.

Insiders Place Their Bets

In other Phreesia news, insider Evan Roberts sold 3,761 shares of the business’s stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $23.28, for a total value of $87,556.08. Following the sale, the insider owned 726,837 shares of the company’s stock, valued at $16,920,765.36. The trade was a 0.51% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, General Counsel Allison C. Hoffman sold 3,133 shares of the stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $23.28, for a total transaction of $72,936.24. Following the completion of the transaction, the general counsel owned 139,037 shares of the company’s stock, valued at approximately $3,236,781.36. This represents a 2.20% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 26,174 shares of company stock valued at $603,835 in the last ninety days. 5.50% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. BMO Capital Markets began coverage on shares of Phreesia in a research report on Thursday, November 13th. They set an “outperform” rating and a $32.00 target price for the company. Piper Sandler lifted their price objective on Phreesia from $33.00 to $34.00 and gave the stock an “overweight” rating in a research note on Friday, September 5th. JMP Securities boosted their price objective on Phreesia from $30.00 to $34.00 and gave the stock a “market outperform” rating in a research report on Monday, September 8th. Stephens reaffirmed an “overweight” rating and issued a $32.00 target price on shares of Phreesia in a report on Wednesday, September 3rd. Finally, Canaccord Genuity Group lifted their price target on Phreesia from $34.00 to $38.00 and gave the stock a “buy” rating in a research report on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, Phreesia has a consensus rating of “Moderate Buy” and a consensus target price of $33.71.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.